Welcome to Temtia 9.5!

We’re delighted to announce that the Temtia 9.5 Virtual Conference ‘Targeting EMT’ will be held from December 14 – 17, 2021. Focussed on the clinical translation of EMP, the session themes are:

  • Immunosensitisation / Immunotherapy
  • Prognostic/Predictive EMT signatures.
  • Targeting EMT

There will be the opportunity for face-to-face virtual interaction and posters for one hour before and after each session. A key objective will be to engage Pharma with EMT, and each session will end with a Discussion moderated by a dedicated panel, primarily from Pharma.

The early bird registration rate for the entire conference including live presentations, Q&A, panel discussions, poster sessions and informal discussions is only $30 (Australian dollars), increasing to $50 after 10 December 2021. Registered delegates can submit abstracts via this link. For further details please see the conference flyer.

Immediate Past President

Pierre Savagner

Dr Pierre Savagner
INSERM U1186
Gustave Roussy Cancer Hospital
Villejuif, France

Contact details:
t: +33 (0)331-4211-4084
e: pierre.savagner@inserm.fr

Treasurer

Christine Chaffer

A/Prof Christine Chaffer
Kinghorn Cancer Centre
Garvan Institute of Medical Research
370 Victoria Street
Darlinghurst NSW 2010
Australia

Contact details:
t: +61 2 9355 5824
e: c.chaffer@garvan.org.au

Secretary

Tian Hong

Associate Professor Tian Hong
Department of Biological Sciences
The University of Texas at Dallas
800 W Campbell Rd
Richardson, TX, US

Contact details:
t: +1-972-883-6027
e: hong@utdallas.edu

Vice-President

Ruby Huang

Prof Ruby Huang
School of Medicine
College of Medicine
National Taiwan University
Taiwan

Contact details:
t: +65 9146 9101
e: rubyhuang@ntu.edu.tw

President

Marc Stemmler

Dr Marc Stemmler
Department of Experimental Medicine
Nikolaus-Fiebiger Center for Molecular Medicine
University of Erlangen-Nürnberg
Glückstr.6, 91054 Erlangen
Germany

Contact details:
t: +49 9131 85 29101
e: marc.stemmler@fau.de